*ST双成 (002693)
Hainan Shuangcheng Pharmaceuticals Co.,Ltd.
K-Line Chart
No K-line data available
Company NameHainan Shuangcheng Pharmaceutical Co., Ltd.
Listing Date2012-08-08
Issue Price20RMB
Registered Capital41468.97510k RMB
Legal RepresentativeWang Chengdong
Registered AddressNo. 16 Xingguo Road, Xiuying District, Haikou City, Hainan Province
IndustryChemical Pharmaceuticals
Main BusinessResearch, development, production, and sales of pharmaceuticals
Company ProfileHainan Shuangcheng Pharmaceutical Co., Ltd., founded in 2000, is a high-tech enterprise specializing in chemically synthesized polypeptide drugs, professionally engaged in pharmaceutical R&D, production, and sales. The company was listed on the SME Board of the Shenzhen Stock Exchange on August 8, 2012, with the stock abbreviation "Shuangcheng Pharmaceutical" and stock code "002693".
Stock Details
1. Key Indicators
- Total Shares(W): 41468.98
- Circulating A-Shares(W): 41098.16
- Earnings Per Share(RMB): -0.0061
- Net Assets Per Share(RMB): 0.9426
- Operating Revenue(W RMB): 16890.38
- Total Profit(W RMB): -753.89
- Net Profit Attributable to Parent(W RMB): -252.35
- Net Profit Growth Rate(%): 93.33
- Weighted Return on Equity(%): -0.6400
- Operating Cash Flow Per Share(RMB): 0.0770
- Undistributed Profit Per Share(RMB): -1.0316
- Capital Reserve Per Share(RMB): 0.8920
2. Main Business
The main business covers:
- Research, development, production, and sales of pharmaceutical injections
- Research, development, production, and sales of solid preparations
- Research, development, production, and sales of active pharmaceutical ingredients (APIs)
3. Company Basic Information
- Company Name: Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- Listing Date: 2012-08-08
- Industry: Pharmaceutical Manufacturing
- Address: No. 16 Xingguo Road, Xiuying District, Haikou City, Hainan Province, China
- Website: www.shuangchengmed.com
- Company Profile: The predecessor of Hainan Shuangcheng Pharmaceuticals Co., Ltd., Hainan Shuangcheng Pharmaceutical Co., Ltd., was established on May 22, 2000. On October 9, 2010, it was approved to be restructured into a joint-stock limited company. The company is mainly engaged in the research, development, production, and sales of pharmaceutical injections, solid preparations, and APIs.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Hainan Shuangcheng Investment Co., Ltd. | Corporate Entity | 13651.65 | 33.22 |
| 2 | HSP INVESTMENT HOLDINGS LIMITED | Corporate Entity | 6459.94 | 15.72 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 218.94 | 0.53 |
| 4 | Beijing Jinhui International Investment Co., Ltd. | Corporate Entity | 120.00 | 0.29 |
5. Concept Sectors
- ST Sector
- Hainan Free Trade Port
- Generic Drugs
- CXO Concept
- Assisted Reproduction
- Hepatitis Concept
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information